Santa Monica - Embodimind: Diagnosing and Treating Cognitive Distortion

Daniel’s forthcoming seminar, "Embodimind: Diagnosing and Treating Cognitive Distortion” looks at brain anatomy and physiology to measure the Soma/Psychic interface. The ‘Body’ is the’Mind’ and the ‘Mind’ is the ‘Body. Daniel will introduce a new model for diagnosis, where participants will learn how to combine deductive/analytical reasoning with skills in utilising inductive/intuitive reasoning. Yes, there are more ways to making the appropriate intervention, gaining real skills in integration. Looking at these two forms of gathering patient information, they are both logical but from different perspectives. Just as we misunderstand emotion and feelings, denying their yin/yang integrated duality, we can begin to see the aetiology of the disease. What are the psycho=physical distortions that limit healing. Daniel has that found using traditional medical modelling but without the metaphoric language of the ancients creates a far more accurate diagnosis. Uniting Soma & Psyche into a single condition that is governed by gaining ‘Being'

New research adds to the growing evidence that metabolic health affects the brain and can adversely affect mental health. Among more than 200,000 adults, high glucose and triglycerides and low high-density lipoprotein (HDL) cholesterol were associated with a higher future risk for depression, anxiety, and stress-related disorders. Findings may support closer follow-up of individuals with metabolic dysregulations for the prevention and diagnosis of psychiatric disorders." The findings also suggest additional studies explore whether intervening in cardiometabolic diseases could counteract these associations. The associations between biomarker levels and the risk of developing depression, anxiety, and stress-related disorders through the end of 2020 were examined using Cox proportional hazards regression models.

In addition, nested case-control analyses were conducted within the cohort, including all incident cases of depression, anxiety, and stress-related disorders, and up to 10 control individuals per case who were individually matched to the case by year of birth, sex, and year of enrollment to the AMORIS cohort, using incidence density sampling. Population trajectories were used to illustrate the temporal trends in biomarker levels for cases and controls.

Reference

Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders. JAMA Netw Open. 2024;7(4):e244525. doi:10.1001/jamanetworkopen.2024.4525

ABOUT DANIEL WEBER, DSC PHD

Dr Weber is CEO of Panaxea International Inc., and visiting professor at Tianjin University were he lectures postgraduate students.

Stemming from his work in complementary cancer treatments, Dr. Daniel Weber has authored a number of books including: Breast Cancer - a practitioners guide; Chemotherapy and Botanical Support; Introduction to Integrative Oncology; Herbs, compounds and supplements in the treatment of cancer; The Seven Stochastic Events of Cancer and ‘Botanical Oncology; isolates’.

Dr. Weber has also authored the unique Botanical Oncology Cancer App, giving practitioners access to fast prescribing. Available on phone or computer.

Since 1992, Dr. Weber has been teaching practitioners about cancer treatment through live seminars and/or webinars, available on request. Dr. Weber has created numerous granular formulas for oncology support as well as many specific isolates targeting tumors directly. Call the office for the free app, and/or the product manual.